Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Lanthanide-Loaded Nanoparticles as Potential Fluorescent and Mass Probes for High-Content Protein Analysis.

Ngamcherdtrakul W, Sangvanich T, Goodyear S, Reda M, Gu S, Castro DJ, Punnakitikashem P, Yantasee W.

Bioengineering (Basel). 2019 Mar 15;6(1). pii: E23. doi: 10.3390/bioengineering6010023.

2.

Draft genome sequence of Lactobacillus plantarum C4 (CECT 9567), a potential probiotic strain isolated from kefir.

De Montijo-Prieto S, Castro DJ, Reina JC, Jimenez-Valera M, Ruiz-Bravo A.

Arch Microbiol. 2019 Apr;201(3):409-414. doi: 10.1007/s00203-019-01629-9. Epub 2019 Feb 13.

PMID:
30759265
3.

Study of Bacterial Community Composition and Correlation of Environmental Variables in Rambla Salada, a Hypersaline Environment in South-Eastern Spain.

Oueriaghli N, Castro DJ, Llamas I, Béjar V, Martínez-Checa F.

Front Microbiol. 2018 Jun 21;9:1377. doi: 10.3389/fmicb.2018.01377. eCollection 2018.

4.

Oxidized analogs of Di(1H-indol-3-yl)methyl-4-substituted benzenes are NR4A1-dependent UPR inducers with potent and safe anti-cancer activity.

Sanchez M, Xia Z, Rico-Bautista E, Cao X, Cuddy M, Castro DJ, Correa RG, Chen L, Yu J, Bobkov A, Ruvolo V, Andreeff M, Oshima RG, Matsuzawa SI, Reed JC, Zhang XK, Hansel D, Wolf DA, Dawson MI.

Oncotarget. 2018 May 18;9(38):25057-25074. doi: 10.18632/oncotarget.25285. eCollection 2018 May 18.

5.

Roseovarius ramblicola sp. nov., a moderately halophilic bacterium isolated from saline soil in Spain.

Castro DJ, Cerezo I, Sampedro I, Martínez-Checa F.

Int J Syst Evol Microbiol. 2018 Jun;68(6):1851-1856. doi: 10.1099/ijsem.0.002744. Epub 2018 Apr 17.

PMID:
29664362
6.

Blastomonas quesadae sp. nov., isolated from a saline soil by dilution-to-extinction cultivation.

Castro DJ, Llamas I, Béjar V, Martínez-Checa F.

Int J Syst Evol Microbiol. 2017 Jun;67(6):2001-2007. doi: 10.1099/ijsem.0.001902. Epub 2017 Jun 20.

PMID:
28631592
7.

Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle Platform.

Morry J, Ngamcherdtrakul W, Gu S, Reda M, Castro DJ, Sangvanich T, Gray JW, Yantasee W.

Mol Cancer Ther. 2017 Apr;16(4):763-772. doi: 10.1158/1535-7163.MCT-16-0644. Epub 2017 Jan 30.

8.

ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer.

Strietz J, Stepputtis SS, Preca BT, Vannier C, Kim MM, Castro DJ, Au Q, Boerries M, Busch H, Aza-Blanc P, Heynen-Genel S, Bronsert P, Kuster B, Stickeler E, Brabletz T, Oshima RG, Maurer J.

Oncotarget. 2016 Dec 13;7(50):83278-83293. doi: 10.18632/oncotarget.13086.

9.

Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment.

Ngamcherdtrakul W, Castro DJ, Gu S, Morry J, Reda M, Gray JW, Yantasee W.

Cancer Treat Rev. 2016 Apr;45:19-29. doi: 10.1016/j.ctrv.2016.02.005. Epub 2016 Feb 22. Review.

10.

Therapeutic siRNA for drug-resistant HER2-positive breast cancer.

Gu S, Hu Z, Ngamcherdtrakul W, Castro DJ, Morry J, Reda MM, Gray JW, Yantasee W.

Oncotarget. 2016 Mar 22;7(12):14727-41. doi: 10.18632/oncotarget.7409.

11.

Dermal delivery of HSP47 siRNA with NOX4-modulating mesoporous silica-based nanoparticles for treating fibrosis.

Morry J, Ngamcherdtrakul W, Gu S, Goodyear SM, Castro DJ, Reda MM, Sangvanich T, Yantasee W.

Biomaterials. 2015 Oct;66:41-52. doi: 10.1016/j.biomaterials.2015.07.005. Epub 2015 Jul 10. Erratum in: Biomaterials. 2016 Jan;74:292.

12.

Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted SiRNA Delivery to HER2+ Breast Cancer.

Ngamcherdtrakul W, Morry J, Gu S, Castro DJ, Goodyear SM, Sangvanich T, Reda MM, Lee R, Mihelic SA, Beckman BL, Hu Z, Gray JW, Yantasee W.

Adv Funct Mater. 2015 May 13;25(18):2646-2659.

13.

ROCK1 inhibition promotes the self-renewal of a novel mouse mammary cancer stem cell.

Castro DJ, Maurer J, Hebbard L, Oshima RG.

Stem Cells. 2013 Jan;31(1):12-22. doi: 10.1002/stem.1224.

14.
15.

Transplacental carcinogenesis with dibenzo[def,p]chrysene (DBC): timing of maternal exposures determines target tissue response in offspring.

Shorey LE, Castro DJ, Baird WM, Siddens LK, Löhr CV, Matzke MM, Waters KM, Corley RA, Williams DE.

Cancer Lett. 2012 Apr 1;317(1):49-55. doi: 10.1016/j.canlet.2011.11.010. Epub 2011 Nov 13.

16.

Heteroatom-substituted analogues of orphan nuclear receptor small heterodimer partner ligand and apoptosis inducer (E)-4-[3-(1-Adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid.

Xia Z, Farhana L, Correa RG, Das JK, Castro DJ, Yu J, Oshima RG, Reed JC, Fontana JA, Dawson MI.

J Med Chem. 2011 Jun 9;54(11):3793-816. doi: 10.1021/jm200051z. Epub 2011 May 6.

PMID:
21548569
17.

Targeting drug-metabolizing enzymes for effective chemoprevention and chemotherapy.

Swanson HI, Njar VC, Yu Z, Castro DJ, Gonzalez FJ, Williams DE, Huang Y, Kong AN, Doloff JC, Ma J, Waxman DJ, Scott EE.

Drug Metab Dispos. 2010 Apr;38(4):539-44. doi: 10.1124/dmd.109.031351.

18.

Fetal mouse Cyp1b1 and transplacental carcinogenesis from maternal exposure to dibenzo(a,l)pyrene.

Castro DJ, Baird WM, Pereira CB, Giovanini J, Löhr CV, Fischer KA, Yu Z, Gonzalez FJ, Krueger SK, Williams DE.

Cancer Prev Res (Phila). 2008 Jul;1(2):128-34. doi: 10.1158/1940-6207.CAPR-07-0004. Epub 2008 Mar 19.

19.

Identifying efficacious approaches to chemoprevention with chlorophyllin, purified chlorophylls and freeze-dried spinach in a mouse model of transplacental carcinogenesis.

Castro DJ, Löhr CV, Fischer KA, Waters KM, Webb-Robertson BJ, Dashwood RH, Bailey GS, Williams DE.

Carcinogenesis. 2009 Feb;30(2):315-20. doi: 10.1093/carcin/bgn280. Epub 2008 Dec 10.

20.

Lymphoma and lung cancer in offspring born to pregnant mice dosed with dibenzo[a,l]pyrene: the importance of in utero vs. lactational exposure.

Castro DJ, Löhr CV, Fischer KA, Pereira CB, Williams DE.

Toxicol Appl Pharmacol. 2008 Dec 15;233(3):454-8. doi: 10.1016/j.taap.2008.09.009. Epub 2008 Sep 24.

Supplemental Content

Loading ...
Support Center